Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
Open Access
- 27 February 2020
- Vol. 9 (3), 565
- https://doi.org/10.3390/cells9030565
Abstract
The use of dendritic cells (DCs) to generate effective anti-tumor T cell immunity has garnered much attention over the last thirty-plus years. Despite this, limited clinical benefit has been demonstrated thus far. There has been a revival of interest in DC-based treatment strategies following the remarkable patient responses observed with novel checkpoint blockade therapies, due to the potential for synergistic treatment. Cross-presenting DCs are recognized for their ability to prime CD8+ T cell responses to directly induce tumor death. Consequently, they are an attractive target for next-generation DC-based strategies. In this review, we define the universal classification system for cross-presenting DCs, and the vital role of this subset in mediating anti-tumor immunity. Furthermore, we will detail methods of targeting these DCs both ex vivo and in vivo to boost their function and drive effective anti-tumor responses.Keywords
This publication has 199 references indexed in Scilit:
- Compensatory dendritic cell development mediated by BATF–IRF interactionsNature, 2012
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic CellsImmunity, 2012
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- Id2 expression delineates differential checkpoints in the genetic program of CD8α+and CD103+dendritic cell lineagesThe EMBO Journal, 2011
- Matrix Metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12- and OX40L-Dependent PathwayCancer Cell, 2011
- Inflammatory cytokines as a third signal for T cell activationCurrent Opinion in Immunology, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceNature, 2009
- Role of TLR3 in the immunogenicity of replicon plasmid-based vaccinesGene Therapy, 2008